These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 21688269)

  • 1. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
    Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
    J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
    Girardi G; Redecha P; Salmon JE
    Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity.
    Samarkos M; Mylona E; Kapsimali V
    Semin Arthritis Rheum; 2012 Aug; 42(1):66-9. PubMed ID: 22405029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and the antiphospholipid syndrome.
    Lim W
    Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal expression of cell adhesion molecules in placentae from women with systemic lupus erythematosus and the antiphospholipid syndrome.
    Lakasing L; Campa JS; Parmar K; Poston R; Hunt BJ; Poston L
    Placenta; 2000; 21(2-3):142-9. PubMed ID: 10736236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
    J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guilty as charged: all available evidence implicates complement's role in fetal demise.
    Girardi G
    Am J Reprod Immunol; 2008 Mar; 59(3):183-92. PubMed ID: 18275511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
    Thurman JM; Kraus DM; Girardi G; Hourcade D; Kang HJ; Royer PA; Mitchell LM; Giclas PC; Salmon J; Gilkeson G; Holers VM
    Mol Immunol; 2005 Jan; 42(1):87-97. PubMed ID: 15488947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.
    Holers VM; Girardi G; Mo L; Guthridge JM; Molina H; Pierangeli SS; Espinola R; Xiaowei LE; Mao D; Vialpando CG; Salmon JE
    J Exp Med; 2002 Jan; 195(2):211-20. PubMed ID: 11805148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice.
    Kawaguchi R; Nunomura S; Umehara N; Nikaido T; Huppertz B; Tanaka T; Ra C
    Placenta; 2012 Jul; 33(7):540-7. PubMed ID: 22538230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
    Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
    Front Immunol; 2019; 10():773. PubMed ID: 31031764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of antiphospholipid antibody-associated pregnancy complications.
    Abrahams VM
    Thromb Res; 2009 Nov; 124(5):521-5. PubMed ID: 19665761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.
    Shamonki JM; Salmon JE; Hyjek E; Baergen RN
    Am J Obstet Gynecol; 2007 Feb; 196(2):167.e1-5. PubMed ID: 17306667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.